134 related articles for article (PubMed ID: 18988868)
1. Phorbol ester-induced PKCepsilon down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation.
Gobbi G; Mirandola P; Carubbi C; Micheloni C; Malinverno C; Lunghi P; Bonati A; Vitale M
Blood; 2009 Mar; 113(13):3080-7. PubMed ID: 18988868
[TBL] [Abstract][Full Text] [Related]
2. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
Rosato RR; Almenara JA; Coe S; Grant S
Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced down-modulation of PKCepsilon promotes trail-mediated apoptosis of tumor cells.
Gobbi G; Masselli E; Micheloni C; Nouvenne A; Russo D; Santi P; Matteucci A; Cocco L; Vitale M; Mirandola P
Int J Oncol; 2010 Sep; 37(3):719-29. PubMed ID: 20664941
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.
Bansal H; Seifert T; Bachier C; Rao M; Tomlinson G; Iyer SP; Bansal S
J Biol Chem; 2012 Sep; 287(39):32875-80. PubMed ID: 22898820
[TBL] [Abstract][Full Text] [Related]
5. Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
Kong X; Luo J; Xu T; Zhou Y; Pan Z; Xie Y; Zhao L; Lu Y; Han X; Li Z; Liu L
Oncol Rep; 2017 Jun; 37(6):3423-3432. PubMed ID: 28498435
[TBL] [Abstract][Full Text] [Related]
6. Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells.
Tazzari PL; Tabellini G; Ricci F; Papa V; Bortul R; Chiarini F; Evangelisti C; Martinelli G; Bontadini A; Cocco L; McCubrey JA; Martelli AM
Cancer Res; 2008 Nov; 68(22):9394-403. PubMed ID: 19010914
[TBL] [Abstract][Full Text] [Related]
7. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.
Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X
Oncogene; 2008 Apr; 27(18):2513-24. PubMed ID: 17982483
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
9. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
[TBL] [Abstract][Full Text] [Related]
10. The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells.
Nathwani SM; Greene LM; Butini S; Campiani G; Williams DC; Samali A; Szegezdi E; Zisterer DM
Int J Oncol; 2016 Jul; 49(1):74-88. PubMed ID: 27176505
[TBL] [Abstract][Full Text] [Related]
11. X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery.
Zhou J; Lu X; Tan TZ; Chng WJ
Mol Oncol; 2018 Jan; 12(1):33-47. PubMed ID: 29063676
[TBL] [Abstract][Full Text] [Related]
12. Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis.
Sarkar S; Faller DV
Nucleic Acid Ther; 2013 Jun; 23(3):167-74. PubMed ID: 23634944
[TBL] [Abstract][Full Text] [Related]
13. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.
Luan Z; He Y; He F; Chen Z
Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816
[TBL] [Abstract][Full Text] [Related]
14. Osteoblasts display different responsiveness to TRAIL-induced apoptosis during their differentiation process.
Brunetti G; Oranger A; Carbone C; Mori G; Sardone FR; Mori C; Celi M; Faienza MF; Tarantino U; Zallone A; Grano M; Colucci S
Cell Biochem Biophys; 2013; 67(3):1127-36. PubMed ID: 23677859
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines.
Van Geelen CM; Pennarun B; Ek WB; Le PT; Spierings DC; De Vries EG; De Jong S
Int J Oncol; 2010 Oct; 37(4):1031-41. PubMed ID: 20811726
[TBL] [Abstract][Full Text] [Related]
16. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
17. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.
Secchiero P; Zerbinati C; di Iasio MG; Melloni E; Tiribelli M; Grill V; Zauli G
Curr Drug Metab; 2007 May; 8(4):395-403. PubMed ID: 17504227
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
Seal S; Hockenbery DM; Spaulding EY; Kiem HP; Abbassi N; Deeg HJ
Exp Hematol; 2008 Dec; 36(12):1660-72. PubMed ID: 18838202
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemia.
McLornan D; Hay J; McLaughlin K; Holohan C; Burnett AK; Hills RK; Johnston PG; Mills KI; McMullin MF; Longley DB; Gilkes A
Br J Haematol; 2013 Jan; 160(2):188-98. PubMed ID: 23167276
[TBL] [Abstract][Full Text] [Related]
20. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
